chr20-10412497-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_170784.3(MKKS):c.985+33G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.23 in 1,604,844 control chromosomes in the GnomAD database, including 44,168 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 5121 hom., cov: 32)
Exomes 𝑓: 0.23 ( 39047 hom. )
Consequence
MKKS
NM_170784.3 intron
NM_170784.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.20
Publications
14 publications found
Genes affected
MKKS (HGNC:7108): (MKKS centrosomal shuttling protein) This gene encodes a protein which shares sequence similarity with other members of the type II chaperonin family. The encoded protein is a centrosome-shuttling protein and plays an important role in cytokinesis. This protein also interacts with other type II chaperonin members to form a complex known as the BBSome, which involves ciliary membrane biogenesis. This protein is encoded by a downstream open reading frame (dORF). Several upstream open reading frames (uORFs) have been identified, which repress the translation of the dORF, and two of which can encode small mitochondrial membrane proteins. Mutations in this gene have been observed in patients with Bardet-Biedl syndrome type 6, also known as McKusick-Kaufman syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2023]
MKKS Gene-Disease associations (from GenCC):
- McKusick-Kaufman syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- Bardet-Biedl syndrome 6Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 20-10412497-C-G is Benign according to our data. Variant chr20-10412497-C-G is described in ClinVar as Benign. ClinVar VariationId is 261060.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.301 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MKKS | ENST00000347364.7 | c.985+33G>C | intron_variant | Intron 3 of 5 | 1 | NM_170784.3 | ENSP00000246062.4 | |||
| MKKS | ENST00000399054.6 | c.985+33G>C | intron_variant | Intron 3 of 5 | 1 | ENSP00000382008.2 | ||||
| MKKS | ENST00000651692.1 | c.985+33G>C | intron_variant | Intron 4 of 6 | ENSP00000498849.1 | |||||
| MKKS | ENST00000652676.1 | n.629+33G>C | intron_variant | Intron 4 of 6 |
Frequencies
GnomAD3 genomes AF: 0.255 AC: 38780AN: 151966Hom.: 5109 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
38780
AN:
151966
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.254 AC: 62817AN: 247060 AF XY: 0.246 show subpopulations
GnomAD2 exomes
AF:
AC:
62817
AN:
247060
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.227 AC: 330306AN: 1452758Hom.: 39047 Cov.: 30 AF XY: 0.226 AC XY: 163742AN XY: 723136 show subpopulations
GnomAD4 exome
AF:
AC:
330306
AN:
1452758
Hom.:
Cov.:
30
AF XY:
AC XY:
163742
AN XY:
723136
show subpopulations
African (AFR)
AF:
AC:
10345
AN:
33340
American (AMR)
AF:
AC:
16896
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
AC:
6240
AN:
26106
East Asian (EAS)
AF:
AC:
9881
AN:
39650
South Asian (SAS)
AF:
AC:
18436
AN:
86092
European-Finnish (FIN)
AF:
AC:
9903
AN:
49638
Middle Eastern (MID)
AF:
AC:
1338
AN:
5724
European-Non Finnish (NFE)
AF:
AC:
243216
AN:
1107366
Other (OTH)
AF:
AC:
14051
AN:
60132
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
13011
26022
39033
52044
65055
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8566
17132
25698
34264
42830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.255 AC: 38820AN: 152086Hom.: 5121 Cov.: 32 AF XY: 0.255 AC XY: 18942AN XY: 74336 show subpopulations
GnomAD4 genome
AF:
AC:
38820
AN:
152086
Hom.:
Cov.:
32
AF XY:
AC XY:
18942
AN XY:
74336
show subpopulations
African (AFR)
AF:
AC:
12658
AN:
41470
American (AMR)
AF:
AC:
4630
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
853
AN:
3472
East Asian (EAS)
AF:
AC:
1384
AN:
5172
South Asian (SAS)
AF:
AC:
1115
AN:
4824
European-Finnish (FIN)
AF:
AC:
2148
AN:
10564
Middle Eastern (MID)
AF:
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15210
AN:
67978
Other (OTH)
AF:
AC:
567
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1511
3022
4533
6044
7555
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1047
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.